Chong Kun Dang Pharmaceutical

This early-stage study is testing a new drug called CKD-703 in people with advanced solid tumors, including a specific type of lung cancer. The drug is designed to target cancer cells more precisely to try to shrink tumors while potentially causing fewer side effects. The study w…

This study is for adults with type 2 diabetes whose blood sugar is still too high despite taking two common medications. Researchers want to see if adding one of two different drugs works better to control blood sugar without causing low blood sugar episodes or weight gain. About…

This is a very early study to see how a new drug called CKD-846 moves through the body and how safe it is. It will involve 32 healthy male volunteers. The main goal is to measure the drug's levels in the blood and check for any side effects, not to treat a medical condition.